Quarterly report pursuant to Section 13 or 15(d)

SEGMENT REPORTING - Net Sales and Segment Profit (Details)

v3.23.2
SEGMENT REPORTING - Net Sales and Segment Profit (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Segment Reporting Information [Line Items]        
Segment net sales $ 4,981 $ 4,100 $ 8,959 $ 9,141
Segment loss 2,726 2,481 4,960 5,074
Non-cash share-based compensation     (901) (1,648)
Depreciation and amortization (224) (318) (460) (644)
Loss from operations (3,175) (5,348) (7,305) (15,066)
Loss on debt extinguishment, net 0 0 0 2,263
Loss (Gain) on remeasurement of warrant liability 11 (1,323) 55 (1,813)
Gain on investment 0 (6,851) 0 (6,851)
Foreign exchange loss 67 264 22 475
Interest and amortization of debt issuance cost 35 645 18 2,754
Other (income) expense, net (27) 61 12 9
Loss (income) before income taxes and equity investment loss (3,261) 1,856 (7,412) (11,903)
Operating Segments        
Segment Reporting Information [Line Items]        
Segment net sales 4,981 4,100 8,959 9,141
Segment loss (866) (2,040) (2,734) (7,398)
Operating Segments | Cannabinoid        
Segment Reporting Information [Line Items]        
Segment net sales 1,873 745 3,095 2,553
Segment loss (1,697) (2,706) (4,012) (8,412)
Operating Segments | Non-Cannabinoid        
Segment Reporting Information [Line Items]        
Segment net sales 3,108 3,355 5,864 6,588
Segment loss 831 666 1,278 1,014
Other        
Segment Reporting Information [Line Items]        
Unallocated corporate expenses (2,571) (1,843) (4,129) (5,376)
Non-cash share-based compensation (434) (1,148) (902) (1,648)
Depreciation and amortization 696 (317) 460 (644)
Loss from operations $ (3,175) $ (5,348) $ (7,305) $ (15,066)